Cargando…

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli

BACKGROUND: Production of recombinant drugs in process-friendly endotoxin-free bacterial factories targets to a lessened complexity of the purification process combined with minimized biological hazards during product application. The development of nanostructured recombinant materials in innovative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rueda, Fabián, Céspedes, María Virtudes, Sánchez-Chardi, Alejandro, Seras-Franzoso, Joaquin, Pesarrodona, Mireia, Ferrer-Miralles, Neus, Vázquez, Esther, Rinas, Ursula, Unzueta, Ugutz, Mamat, Uwe, Mangues, Ramón, García-Fruitós, Elena, Villaverde, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826532/ https://www.ncbi.nlm.nih.gov/pubmed/27059706 http://dx.doi.org/10.1186/s12934-016-0457-z

Ejemplares similares

Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs
por: Céspedes, María Virtudes, et al.
Publicado: (2016)

Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste
por: Unzueta, Ugutz, et al.
Publicado: (2022)

Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles
por: Unzueta, Ugutz, et al.
Publicado: (2012)

Functional inclusion bodies produced in the yeast Pichia pastoris
por: Rueda, Fabián, et al.
Publicado: (2016)

Efficient bioactive oligonucleotide‐protein conjugation for cell‐targeted cancer therapy
por: Aviñó, Anna, et al.
Publicado: (2019)

Packaging protein drugs as bacterial inclusion bodies for therapeutic applications
por: Villaverde, Antonio, et al.
Publicado: (2012)

Selective depletion of metastatic stem cells as therapy for human colorectal cancer
por: Céspedes, María Virtudes, et al.
Publicado: (2018)

Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
por: Torrealba, Débora, et al.
Publicado: (2016)

Side effects of chaperone gene co-expression in recombinant protein production
por: Martínez-Alonso, Mónica, et al.
Publicado: (2010)

Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies
por: Pesarrodona, Mireia, et al.
Publicado: (2019)

Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
por: Serna, Naroa, et al.
Publicado: (2021)

A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models
por: Falgàs, Aïda, et al.
Publicado: (2020)

Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles
por: Álamo, Patricia, et al.
Publicado: (2020)

Isolation of cell-free bacterial inclusion bodies
por: Rodríguez-Carmona, Escarlata, et al.
Publicado: (2010)

Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials
por: Serna, Naroa, et al.
Publicado: (2022)

The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies
por: Sánchez, Julieta María, et al.
Publicado: (2022)

Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells
por: Barguilla, Irene, et al.
Publicado: (2022)

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases
por: Sala, Rita, et al.
Publicado: (2022)

Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes
por: Cano-Garrido, Olivia, et al.
Publicado: (2015)

Artificial Inclusion Bodies for Clinical Development
por: Sánchez, Julieta M., et al.
Publicado: (2019)

Ion-dependent slow protein release from in vivo disintegrating micro-granules
por: Álamo, Patricia, et al.
Publicado: (2021)

Recombinant pharmaceuticals from microbial cells: a 2015 update
por: Sanchez-Garcia, Laura, et al.
Publicado: (2016)

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers
por: Cano-Garrido, Olivia, et al.
Publicado: (2021)

In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics
por: Carratalá, Jose V., et al.
Publicado: (2020)

A new approach to obtain pure and active proteins from Lactococcus lactis protein aggregates
por: Gifre-Renom, L., et al.
Publicado: (2018)

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4(+) Diffuse Large B-Cell Lymphoma Cells
por: Falgàs, Aïda, et al.
Publicado: (2021)

Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

Engineered Biological Entities for Drug Delivery and Gene Therapy: Protein Nanoparticles
por: Domingo-Espín, Joan, et al.
Publicado: (2011)

The Potential of Metalloproteinase-9 Administration to Accelerate Mammary Involution and Boost the Immune System at Dry-Off
por: Parés, Sílvia, et al.
Publicado: (2021)

Selecting Subpopulations of High-Quality Protein Conformers among Conformational Mixtures of Recombinant Bovine MMP-9 Solubilized from Inclusion Bodies
por: Carratalá, Jose Vicente, et al.
Publicado: (2021)

Biofabrication of functional protein nanoparticles through simple His-tag engineering
por: López-Laguna, Hèctor, et al.
Publicado: (2021)

Selective delivery of T22-PE24-H6 to CXCR4(+) diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
por: Falgàs, Aïda, et al.
Publicado: (2020)

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
por: Núñez, Yáiza, et al.
Publicado: (2023)

Bacterial cell factories for recombinant protein production; expanding the catalogue
por: Ferrer-Miralles, Neus, et al.
Publicado: (2013)

Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized Protocol
por: Fernández, Roger, et al.
Publicado: (2022)

uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy
por: Pavón, Miguel Angel, et al.
Publicado: (2016)

An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
por: Pallarès, Victor, et al.
Publicado: (2020)

Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors
por: Mira, Alessia, et al.
Publicado: (2017)

Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials
por: Sánchez-García, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uf8uvtvd964s1in623c4mc9n0a